Oncoinvent is a biotechnology company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose.
Øystein Soug
CEO
Ramzi Amri
CFO
thematic
Healthcare
thematic
Healthcare
thematic
Healthcare